anti human ulbp3 antibodies (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
anti human ulbp3 antibodies
Anti Human Ulbp3 Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulbp3/Human+ULBP-3+Antibody/pm41529511-90-13-19
Average 94 stars, based on 15 article reviews
Anti Human Ulbp3 Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ulbp3/Human+ULBP-3+Antibody/pm41529511-90-13-19
Average 94 stars, based on 15 article reviews
anti human ulbp3 antibodies - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Control:Article Title: Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies Article Snippet: .. Boyle), Recombinant:Article Title: Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL Article Snippet: Flow cytometry experiments were performed using antibodies directed against human CD4 (560158, BD Biosciences), CD8 (561453, BD Biosciences), CD19 (562441, BD Biosciences), CD25 (53-0259-42, ThermoFisher), CD34 (343516, Biolegend), CD45RA (564552, BD Biosciences), CD62L (25-0629-42, ThermoFisher), CD69 (555533, BD Biosciences), CD107a (328620, Biolegend), CD279 (12-2799-42, ThermoFisher), TIGIT (372714, Biolegend) and TCRα/β (130-113-527, Miltenyi). .. NKG2DL were detected using antibodies directed against human MICA (FAB1300P, R&D systems), MICB (FAB1599P, R&D systems), ULBP1 (FAB1380P, R&D systems), Bioprocessing:Article Title: Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres Article Snippet: Monoclonal antibodies against CD16, recombinant human IFN-, M-CSF, conjugated primary antibodies against CD3/16/56, CD45, CD19, CD14, CD4, CD8, CD3, HLA-DR (MHC class II), CD44, CD54, MHC class I, PD-L1 (B7-H1), CD155, MICA/B, CD112, HLA-E, unconjugated primary antibodies against GFAP and PE-conjugated anti-mouse secondary antibodies were purchased from Biolegend (San Diego, CA, USA). .. Monoclonal antibodies against CD16, CD45, ULBP1, Flow Cytometry:Article Title: Reducing fratricide of immune cells expressing NKG2D-based receptors Article Snippet: These results indicate that target-driven fratricide can be overcome using different approaches that can enable the development of T cell therapies where self-expression of the target ligand is a limiting factor. .. Materials and Methods Antibodies and Flow Cytometry Cells were stained with fluorochrome labeled CD3 (BD, 345766), CD4 (BD, 345809), CD8 (BD, 345772), CD314 (BD, 558071), CD45RA (BD, 550855), CD62L (BD, 555544), CD279 (eBioscience, 12-2799-42), CD19 (BD, 345791, CD223 (eBioscience, 25-2239-41), MICA/B (R&D Systems, FAB13001G-100), MICB (R&D Systems, FAB1599G), ULBP1 (R&D Systems, FAB1380C), ULBP2/5/6 (R&D Systems, FAB1298A), Staining:Article Title: Reducing fratricide of immune cells expressing NKG2D-based receptors Article Snippet: These results indicate that target-driven fratricide can be overcome using different approaches that can enable the development of T cell therapies where self-expression of the target ligand is a limiting factor. .. Materials and Methods Antibodies and Flow Cytometry Cells were stained with fluorochrome labeled CD3 (BD, 345766), CD4 (BD, 345809), CD8 (BD, 345772), CD314 (BD, 558071), CD45RA (BD, 550855), CD62L (BD, 555544), CD279 (eBioscience, 12-2799-42), CD19 (BD, 345791, CD223 (eBioscience, 25-2239-41), MICA/B (R&D Systems, FAB13001G-100), MICB (R&D Systems, FAB1599G), ULBP1 (R&D Systems, FAB1380C), ULBP2/5/6 (R&D Systems, FAB1298A), Labeling:Article Title: Reducing fratricide of immune cells expressing NKG2D-based receptors Article Snippet: These results indicate that target-driven fratricide can be overcome using different approaches that can enable the development of T cell therapies where self-expression of the target ligand is a limiting factor. .. Materials and Methods Antibodies and Flow Cytometry Cells were stained with fluorochrome labeled CD3 (BD, 345766), CD4 (BD, 345809), CD8 (BD, 345772), CD314 (BD, 558071), CD45RA (BD, 550855), CD62L (BD, 555544), CD279 (eBioscience, 12-2799-42), CD19 (BD, 345791, CD223 (eBioscience, 25-2239-41), MICA/B (R&D Systems, FAB13001G-100), MICB (R&D Systems, FAB1599G), ULBP1 (R&D Systems, FAB1380C), ULBP2/5/6 (R&D Systems, FAB1298A), other:Article Title: Methods for selective expansion of gamma delta t-cell populations and compositions thereof Article Snippet: In some embodiments, γδ T-cells activators can include γδ TCR-binding agents such as MICA, an agonist antibody to NKG2D, an, e.g., Fc tag, fusion protein of MICA, ULBP1, or Article Title: Engineered γδ T-cells Article Snippet: In some embodiments, γδ T-cells activators can include γδ TCR-binding agents such as MICA, agonist antibody to NKG2D, (Fc tag) fusion protein of MICA, ULBP1, |